Pharmaceutical Executive January 16, 2024
Soaring healthcare costs show little sign of slowing in 2024, with concerns growing about the affordability of medications and medical services.
My colleagues at Business Group on Health and I huddle each year to make predictions for the months ahead, in terms of healthcare cost and delivery, well‐being and workforce strategy. These unique observations, directly tied to the Business Group’s original research and other findings, comprise our annual “Trends to Watch.”
I’d like to share a few highlights of what we’ve identified for 2024, which includes crucial challenges for our 440-plus members representing large, self-insured employers and others across the industry.
First, we will be keenly focused on healthcare costs, which will continue to surge and will result in heightened...
Today's Sponsors
Today's Sponsor